Galaxy chemical evolution models: The role of molecular gas formation

In our classical grid of multiphase chemical evolution models, star formation in the disc occurs in two steps: first, molecular gas forms, and then stars are created by cloud-cloud collisions or interactions of massive stars with the surrounding molecular clouds. The formation of both molecular clouds and stars are treated through the use of free parameters we refer to as efficiencies. In this work, we modify the formation of molecular clouds based on several new prescriptions existing in the literature, and we compare the results obtained for a chemical evolution model of theMilkyWay Galaxy regarding the evolution of the Solar region, the radial structure of the Galactic disc and the ratio between the diffuse and molecular components, H I /H 2 . Our results show that the six prescriptions we have tested reproduce fairly consistent most of the observed trends, differing mostly in their predictions for the (poorly constrained) outskirts of the Milky Way and the evolution in time of its radial structure. Among them, the model proposed by Ascasibar et al. (in preparation), where the conversion of diffuse gas into molecular clouds depends on the local stellar and gas densities as well as on the gas metallicity, seems to provide the best overall match to the observed data

Evaluación Bidimensional y Tridimensional de la Vía Aérea Superior

Indexación: Scopus; Scielo.The aim of this study was to validate and correlate the two-dimensional (2D) with the three-dimensional (3D) measures of the upper airway assessment. Lateral cephalograms and cone beam CT of 100 adult subjects were used to perform a 2D and 3D assessment of the upper airway. Spearman correlation coefficient was used to determine whether there was correlation between variables. Additionally, specificity, sensitivity, negative predictive value and positive predictive value was calculated for the 2D assessment of the upper airway. Correlation between all two and three dimensional variables was found. In the nasopharynx and oropharynx, a weak correlation (r <0.51) was found; in the oropharynx a moderate one (0.50 <r <0.76). The validity tests of the 2D assessment resulted in a 73% sensitivity, 45% specificity, 93% negative predictive value and 14% positive predictive value for the nasopharynx; 100% sensitivity, 51% specificity, 100% negative predictive value and 6% positive predictive value in the oropharynx and 100% sensitivity, 71% specificity, 100% negative predictive value and 13% positive predictive value in the hypopharynx. There is a weak correlation between the 2D and 3D assessment of the upper airway. However, the lateral cephalogram has a high sensitivity and high negative predictive value, therefore, an additional complementary examination would not be necessary if the 2D assessment of the upper airway throws a normal result.http://ref.scielo.org/mpkrn

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer

BACKGROUND: Even though liver kinase B1 (LKB1) is usually described as a tumor suppressor in a wide variety of tissues, it has been shown that LKB1 aberrant expression is associated with bad prognosis in Hepatocellular Carcinoma (HCC). METHODS: Herein we have overexpressed LKB1 in human hepatoma cells and by using histidine pull-down assay we have investigated the role of the hypoxia-related post-translational modification of Small Ubiquitin-related Modifier (SUMO)ylation in the regulation of LKB1 oncogenic role. Molecular modelling between LKB1 and its interactors, involved in regulation of LKB1 nucleocytoplasmic shuttling and LKB1 activity, was performed. Finally, high affinity SUMO binding entities-based technology were used to validate our findings in a pre-clinical mouse model and in clinical HCC. FINDINGS: We found that in human hepatoma cells under hypoxic stress, LKB1 overexpression increases cell viability and aggressiveness in association with changes in LKB1 cellular localization. Moreover, by using site-directed mutagenesis, we have shown that LKB1 is SUMOylated by SUMO-2 at Lys178 hampering LKB1 nucleocytoplasmic shuttling and fueling hepatoma cell growth. Molecular modelling of SUMO modified LKB1 further confirmed steric impedance between SUMOylated LKB1 and the STe20-Related ADaptor cofactor (STRADα), involved in LKB1 export from the nucleus. Finally, we provide evidence that endogenous LKB1 is modified by SUMO in pre-clinical mouse models of HCC and clinical HCC, where LKB1 SUMOylation is higher in fast growing tumors. INTERPRETATION: Overall, SUMO-2 modification of LKB1 at Lys178 mediates LKB1 cellular localization and its oncogenic role in liver cancer. FUND: This work was supported by grants from NIH (US Department of Health and Human services)-R01AR001576-11A1 (J.M.M and M.L.M-C.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C), ELKARTEK 2016, Departamento de Industria del Gobierno Vasco (to M.L.M.-C), MINECO: SAF2017-87301-R and SAF2014-52097-R integrado en el Plan Estatal de Investigación Cientifica y Técnica y Innovación 2013-2016 cofinanciado con Fondos FEDER (to M.L.M.-C and J.M.M., respectively), BFU2015-71017/BMC MINECO/FEDER, EU (to A.D.Q. and I.D.M.), BIOEF (Basque Foundation for Innovation and Health Research): EITB Maratoia BIO15/CA/014; Instituto de Salud Carlos III:PIE14/00031, integrado en el Plan Estatal de Investigación Cientifica y Técnica y Innovacion 2013-2016 cofinanciado con Fondos FEDER (to M.L.M.-C and J.M.M), Asociación Española contra el Cáncer (T.C.D, P·F-T and M.L.M-C), Daniel Alagille award from EASL (to T.C.D), Fundación Científica de la Asociación Española Contra el Cancer (AECC Scientific Foundation) Rare Tumor Calls 2017 (to M.L.M and M.A), La Caixa Foundation Program (to M.L.M), Programma di Ricerca Regione-Università 2007-2009 and 2011-2012, Regione Emilia-Romagna (to E.V.), Ramón Areces Foundation and the Andalusian Government (BIO-198) (A.D.Q. and I.D.M.), ayudas para apoyar grupos de investigación del sistema Universitario Vasco IT971-16 (P.A.), MINECO:SAF2015-64352-R (P.A.), Institut National du Cancer, FRANCE, INCa grant PLBIO16-251 (M.S.R.), MINECO - BFU2016-76872-R to (E.B.). Work produced with the support of a 2017 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation (M.V-R). Finally, Ciberehd_ISCIII_MINECO is funded by the Instituto de Salud Carlos III. We thank MINECO for the Severo Ochoa Excellence Accreditation to CIC bioGUNE (SEV-2016-0644). Funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication

A photometric comprehensive study of circumnuclear star forming rings: the sample

We present photometry in U, B, V, R and I continuum bands and in H$\alpha$ and H$\beta$ emission lines for a sample of 336 circumnuclear star forming regions (CNSFR) located in early type spiral galaxies with different levels of activity in their nuclei. They are nearby galaxies, with distances less than 100 Mpc, 60\% of which are considered as interacting objects. This survey of 20 nuclear rings aims to provide insight into their star formation properties as age, stellar population and star formation rate. Extinction corrected H$\alpha$ luminosities range from $1.3\times 10^{38}$ to $4\times 10^{41} erg s^{-1}$, with most of the regions showing values between 39.5 $\leq log L(H\alpha) \leq$ 40, which implies masses for the ionizing clusters higher than $2\times 10^{5} M_\odot$. H$\alpha$ and H$\beta$ images have allowed us to obtain an accurate measure of extinction. We have found an average value of A$_V$ = 1.85 magnitudes. (U-B) colour follows a two maximum distribution around (U-B)$\simeq$ -0.7, and -0.3; (R-I) also presents a bimodal behaviour, with maximum values of 0.6 and 0.9. Reddest (U-B) and (R-I) regions appear in non-interacting galaxies. Reddest (R-I) regions lie in strongly barred galaxies. For a significant number of HII regions the observed colours and equivalent widths are not well reproduced by single burst evolutionary theoretical models.Comment: Accepted for publication in MNRAS. Accepted 15 May 2015. Received, 21 April 201

On the existence threshold for positive solutions of p-laplacian equations with a concave-convex nonlinearity

We study the following boundary value problem with a concave-convex nonlinearity: \begin{equation*} \left\{ \begin{array}{r c l l} -\Delta_p u & = & \Lambda\,u^{q-1}+ u^{r-1} & \textrm{in }\Omega, \\ u & = & 0 & \textrm{on }\partial\Omega. \end{array}\right. \end{equation*} Here $\Omega \subset \mathbb{R}^n$ is a bounded domain and $1<q<p<r<p^*$. It is well known that there exists a number $\Lambda_{q,r}>0$ such that the problem admits at least two positive solutions for $0<\Lambda<\Lambda_{q,r}$, at least one positive solution for $\Lambda=\Lambda_{q,r}$, and no positive solution for $\Lambda > \Lambda_{q,r}$. We show that $$\lim_{q \to p} \Lambda_{q,r} = \lambda_1(p),$$ where $\lambda_1(p)$ is the first eigenvalue of the p-laplacian. It is worth noticing that $\lambda_1(p)$ is the threshold for existence/nonexistence of positive solutions to the above problem in the limit case $q=p$